PALM BEACH GARDENS, FL., Jan 29 –(HSMN NewsFeed)– Eyetech Inc. announced today the results of a preliminary study assessing the investigational use of Macugen for macular edema secondary to branch retinal vein occlusion (BRVO) that were published in the …
Biopharmaceuticals, Ophthalmology
Eyetech, Macugen, branch retinal vein occlusion

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Study Published in the American Journal of Ophthalmology Examines Investigational Use of Macugen in Patients With Branch Retinal Vein Occlusion (BRVO)”
Leave a Comment